Brandywine Managers’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.7K | Hold |
28,488
| – | – | 0.1% | 36 |
|
|
2025
Q1 | $63.5K | Hold |
28,488
| – | – | 0.08% | 35 |
|
|
2024
Q4 | $83.5K | Hold |
28,488
| – | – | 0.09% | 37 |
|
|
2024
Q3 | $74.1K | Hold |
28,488
| – | – | 0.08% | 35 |
|
|
2024
Q2 | $84.3K | Sell |
28,488
-28,488
| -50% | -$84.3K | 0.09% | 36 |
|
|
2024
Q1 | $258K | Hold |
56,976
| – | – | 0.25% | 35 |
|
|
2023
Q4 | $325K | Hold |
56,976
| – | – | 0.36% | 35 |
|
|
2023
Q3 | $262K | Hold |
56,976
| – | – | 0.44% | 33 |
|
|
2023
Q2 | $368K | Hold |
56,976
| – | – | 0.24% | 39 |
|
|
2023
Q1 | $430K | Hold |
56,976
| – | – | 0.31% | 34 |
|
|
2022
Q4 | $577K | Hold |
56,976
| – | – | 2.02% | 15 |
|
|
2022
Q3 | $563K | Hold |
56,976
| – | – | 1.85% | 21 |
|
|
2022
Q2 | $607K | Buy |
56,976
+16,885
| +42% | +$180K | 1.49% | 20 |
|
|
2022
Q1 | $391K | Buy |
40,091
+2,827
| +8% | +$27.6K | 0.67% | 34 |
|
|
2021
Q4 | $533K | Buy |
37,264
+6,545
| +21% | +$93.6K | 0.6% | 34 |
|
|
2021
Q3 | $616K | Buy |
30,719
+5,612
| +22% | +$113K | 0.64% | 31 |
|
|
2021
Q2 | $552K | Buy |
25,107
+5,735
| +30% | +$126K | 0.63% | 33 |
|
|
2021
Q1 | $658K | Buy |
19,372
+10,436
| +117% | +$354K | 0.87% | 26 |
|
|
2020
Q4 | $360K | Buy |
+8,936
| New | +$360K | 0.5% | 34 |
|